Damian McNamara
News
CDC data strengthen link between obesity and severe COVID
March 9, 2021
Progressively intensive management of COVID-19 might be needed for patients with more severe obesity.
News
Dining restrictions, mask mandates tied to less illness, death, CDC reaffirms
March 8, 2021
“When prevention measures like mask-wearing mandates are lifted, cases go up.”
News
COVID-19 vaccination linked to less mechanical ventilation
March 1, 2021
A new paper offers a “real-world” look at vaccination effectiveness, according to the authors.
![1]()
News
FDA grants emergency use authorization to Johnson & Johnson COVID-19 vaccine
February 27, 2021
“The advantages of having a third vaccine, especially one that is a single shot and can be stored without special refrigeration requirements, will be a major contribution in getting the general public vaccinated sooner.”
![1]()
News
Janssen/J&J COVID-19 vaccine cuts transmission, new data show
February 24, 2021
"The decrease in asymptomatic transmission is very welcome news too in curbing the spread of the virus."
News
J&J vaccine 85% efficacious against severe COVID globally
February 1, 2021
The efficacy against severe disease provided by the Janssen/J&J vaccine held true regardless of age, race/ethnicity, absence or presence of comorbidities, and geography.
News
More than one-third of COVID-19 infections are asymptomatic: Review
January 26, 2021
“To reduce transmission from people who are presymptomatic or asymptomatic, we need to shift our testing focus to at-home screening.”
Article
What we know and don’t know about virus variants and vaccines
January 22, 2021
One of the major concerns remains the ability of COVID-19 vaccines to work on new strains.
![1]()
News
Arthritis drugs ‘impressive’ for severe COVID but not ‘magic cure’
January 15, 2021
U.S. and U.K. experts weigh in on research that compares monoclonal antibody therapies with usual care for people critically ill with COVID-19.
News
The next likely COVID-19 vaccine has its advantages
January 15, 2021
A single Ad26.COV2.S dose was associated with S-binding and neutralizing antibodies in more than 90% of the participants.
